INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![vendor-support-clinical-trials]( "The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast")
The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears FastDiscover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.
-
![GettyImages-487610898 Vendors]( "The Ten Commandments Of Vendor Management")
The Ten Commandments Of Vendor ManagementMaster trial governance with 10 core principles. Learn how tracking trends, rewarding transparency, and early escalation ensure long-term trial success.
-
![clinical-compliance-GettyImages-2259718661]( "Urgent Compliance Recovery Following Vendor Transition")
Urgent Compliance Recovery Following Vendor TransitionStrong local leadership, clear ownership, and governed oversight drove rapid remediation of legacy safety gaps, restoring regulatory confidence and safeguarding market continuity.
-
![Comparator Selection And Supply]( "Comparator Selection And Supply: Best Practices For Clinical Success")
Comparator Selection And Supply: Best Practices For Clinical SuccessExplore best practices for comparator selection and supply optimization in clinical trials, including sourcing strategies, risk mitigation, regulatory compliance, and real-world cost-saving case studies.
-
The Shift Toward Self-Administration And Integrated Supply Chains4/15/2026
Adopt integrated, end-to-end clinical supply strategies that enable self-administered therapies, reduce patient burden, and accelerate clinical trial timelines while improving access and outcomes.
-
Expand Bandwidth With A Trusted Regulatory Writing Partner9/18/2025
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
Executing Pediatric Gene Therapy Trials At The Site Level5/29/2026
Pediatric gene therapy trials demand exceptional coordination at the site level, and these frontline insights can help you manage protocol complexity and balance operations with family‑centered care.
-
Retention Through Intention — Designing Truly Patient-Centric Trials2/4/2026
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Supporting Early Phase Research Through Collaboration")
Early phase trials demand speed and precision. Discover a partnership providing specialized expertise that keeps your program on track.
-
![GettyImages-2163190867-hospital-doctor-administrator-discussion]( "Sponsors And CROs")
Our aim is to ensure the flawless and successful execution of clinical research, maximizing its impact on both patients and the commercial market.
-
![GettyImages-1165109678-handshake-partner-business-agreement]( "Proven Expertise With Global Solutions For U.S. Biotechs")
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.
-
![GettyImages-1294339697-computer-monitor-test-research-controls]( "Managing Execution Of A Phase III Clinical Trial")
Clinical trials must accommodate operational challenges and changes in the market, which includes a sponsor's ability to forecast site activation, monitor resources, and track competitive activity.
-
![Zillion pills-GettyImages-157287767]( "Drug-Drug Interaction Clinical Trials")
We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.
